Replimune Group, Inc. (REPL)
8.105
+0.08
(+0.93%)
USD |
NASDAQ |
Jan 12, 16:00
8.24
+0.14
(+1.67%)
Pre-Market: 08:34
Replimune Group Price: 8.105 for Jan. 12, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Rapt Therapeutics, Inc. | 34.40 |
| Olema Pharmaceuticals, Inc. | 28.79 |
| CorMedix, Inc. | 7.15 |
| Verastem, Inc. | 7.11 |
| Anavex Life Sciences Corp. | 4.29 |
Price Related Metrics
| PEG Ratio | -0.1425 |
| Price to Book Value | 2.414 |
| Earnings Yield | -44.51% |
| Market Cap | 635.78M |
| PEGY Ratio | -0.1425 |